Genetic Engineering News

<img alt="" height="1" width="1" />
Pfizer drug meets rheumatoid arthritis study goals
Drug developer Pfizer Inc. said Thursday that its potential rheumatoid arthritis drug met key treatment goals in two late-stage studies. The drug candidate tofacitinib, formerly called tasocitinib, met its key goals of reducing signs and symptoms of ...
Pfizer&#39;s Tofacitinib Takes Next Step To Combat ArthritisMedical News Today
Pfizer arthritis drug makes more steps forward in
Pfizer Says ORAL Standard Study Met All Primary Endpoints >PFEWall Street Journal
Reuters -Forbes (blog) -FierceBiotech
all 33 news articles &raquo;